[New therapy of dermatomyositis and scleroderma].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy*; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010118:Oxytetracycline / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014665:Vasodilator Agents; D004917:Erythromycin; D010118:Oxytetracycline
Neue Therapie von Dermatomyositis und Sklerodermie.